206 related articles for article (PubMed ID: 30371159)
1. Prior Direct Oral Anticoagulant Therapy is Related to Small Infarct Volume and No Major Artery Occlusion in Patients With Stroke and Non-Valvular Atrial Fibrillation.
Sakamoto Y; Okubo S; Sekine T; Nito C; Suda S; Matsumoto N; Nishiyama Y; Aoki J; Shimoyama T; Kanamaru T; Suzuki K; Mishina M; Kimura K
J Am Heart Assoc; 2018 Sep; 7(17):e009507. PubMed ID: 30371159
[TBL] [Abstract][Full Text] [Related]
2. The relationship between stroke severity and prior direct oral anticoagulant therapy in patients with acute ischaemic stroke and non-valvular atrial fibrillation.
Sakamoto Y; Okubo S; Nito C; Suda S; Matsumoto N; Abe A; Aoki J; Shimoyama T; Takayama Y; Suzuki K; Mishina M; Kimura K
Eur J Neurol; 2017 Nov; 24(11):1399-1406. PubMed ID: 28799181
[TBL] [Abstract][Full Text] [Related]
3. Trends in anticoagulant prescribing: a review of local policies in English primary care.
Ho KH; van Hove M; Leng G
BMC Health Serv Res; 2020 Apr; 20(1):279. PubMed ID: 32245380
[TBL] [Abstract][Full Text] [Related]
4. Effect of direct oral anticoagulant for acute major cerebral artery occlusion in cardioembolic stroke/transient ischemic attack patients with non-valvular atrial fibrillation.
Tomari S; Arima J; Yoshida T; Yamashita H; Sata R; Hamada R; Kanda N; Takashima H
J Neurol Sci; 2019 Jul; 402():162-166. PubMed ID: 31152970
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease.
Lopes RD; Steffel J; Di Fusco M; Keshishian A; Luo X; Li X; Masseria C; Hamilton M; Friend K; Gupta K; Mardekian J; Pan X; Baser O; Jones WS
Am J Med; 2018 Sep; 131(9):1075-1085.e4. PubMed ID: 29807001
[TBL] [Abstract][Full Text] [Related]
6. Cerebral Ischemia in Patients on Direct Oral Anticoagulants.
Macha K; Marsch A; Siedler G; Breuer L; Strasser EF; Engelhorn T; Schwab S; Kallmünzer B
Stroke; 2019 Apr; 50(4):873-879. PubMed ID: 30852963
[TBL] [Abstract][Full Text] [Related]
7. Insufficient Warfarin Therapy Is Associated With Higher Severity of Stroke Than No Anticoagulation in Patients With Atrial Fibrillation and Acute Anterior-Circulation Stroke.
Sakamoto Y; Okubo S; Nito C; Suda S; Matsumoto N; Nishiyama Y; Aoki J; Shimoyama T; Kanamaru T; Suzuki K; Mishina M; Kimura K
Circ J; 2018 Apr; 82(5):1437-1442. PubMed ID: 29269702
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
Am J Cardiol; 2016 Jul; 118(2):210-4. PubMed ID: 27236255
[TBL] [Abstract][Full Text] [Related]
9. [Anticoagulation for patients with non-valvular atrial fibrillation].
Mizoguchi T; Yasaka M
Nihon Rinsho; 2016 Apr; 74(4):627-33. PubMed ID: 27333751
[TBL] [Abstract][Full Text] [Related]
10. The importance of time in therapeutic range in switching from vitamin K antagonist to non-vitamin K antagonist oral anticoagulants in atrial fibrillation.
Vinding NE; Bonde AN; Rørth R; Lamberts M; Olesen JB; Gislason GH; Torp-Pedersen C; Køber L; Fosbøl EL
Europace; 2019 Apr; 21(4):572-580. PubMed ID: 30508073
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non-Vitamin K Antagonist Oral Anticoagulants' Administration for Secondary Prevention of Stroke.
Kanai Y; Oguro H; Tahara N; Matsuda H; Takayoshi H; Mitaki S; Onoda K; Yamaguchi S
J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):338-345. PubMed ID: 29033229
[TBL] [Abstract][Full Text] [Related]
12. Improved Stroke Prevention in Atrial Fibrillation After the Introduction of Non-Vitamin K Antagonist Oral Anticoagulants.
Forslund T; Komen JJ; Andersen M; Wettermark B; von Euler M; Mantel-Teeuwisse AK; Braunschweig F; Hjemdahl P
Stroke; 2018 Sep; 49(9):2122-2128. PubMed ID: 30354995
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study.
Wang CL; Wu VC; Kuo CF; Chu PH; Tseng HJ; Wen MS; Chang SH
J Am Heart Assoc; 2018 Aug; 7(15):e009263. PubMed ID: 30371232
[TBL] [Abstract][Full Text] [Related]
14. Use of oral anticoagulants in patients with valvular atrial fibrillation: findings from the NCDR PINNACLE Registry.
Hess PL; Gosch KL; Jani SM; Varosy PD; Bradley SM; Maddox TM; Michael Ho P; Virani SS
Am Heart J; 2021 Oct; 240():58-62. PubMed ID: 34033802
[TBL] [Abstract][Full Text] [Related]
15. Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysis.
Blomström Lundqvist C; Själander S; Garcia Rodriguez LA; Åkerborg Ö; Jin G; Caleyachetty A; Huelsebeck M; Bowrin K; Schaefer B; Mahdessian H; Hofmeister L; Levin LÅ
J Med Econ; 2022; 25(1):1085-1091. PubMed ID: 35997241
[TBL] [Abstract][Full Text] [Related]
16. Cost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients.
Shah A; Shewale A; Hayes CJ; Martin BC
Stroke; 2016 Jun; 47(6):1555-61. PubMed ID: 27103018
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with proximal carotid axis occlusion in patients with acute stroke and atrial fibrillation.
Sakamoto Y; Sato S; Kuronuma Y; Nagatsuka K; Minematsu K; Toyoda K
J Stroke Cerebrovasc Dis; 2014; 23(5):799-804. PubMed ID: 24103668
[TBL] [Abstract][Full Text] [Related]
18. Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: A cohort study using primary care data in Germany.
Collings SL; Lefèvre C; Johnson ME; Evans D; Hack G; Stynes G; Maguire A
PLoS One; 2017; 12(10):e0185642. PubMed ID: 29016695
[TBL] [Abstract][Full Text] [Related]
19. Association Between Treatment With Apixaban, Dabigatran, Rivaroxaban, or Warfarin and Risk for Osteoporotic Fractures Among Patients With Atrial Fibrillation: A Population-Based Cohort Study.
Lau WCY; Cheung CL; Man KKC; Chan EW; Sing CW; Lip GYH; Siu CW; Lam JKY; Lee ACH; Wong ICK
Ann Intern Med; 2020 Jul; 173(1):1-9. PubMed ID: 32423351
[TBL] [Abstract][Full Text] [Related]
20. Use of non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients: insights from a specialist atrial fibrillation clinic.
Lee SI; Sayers M; Lip GY; Lane DA
Int J Clin Pract; 2015 Nov; 69(11):1341-8. PubMed ID: 26234557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
